Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
V0018 (Nicopass) for Smoking Craving
NCT02359201Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Nicopass in nicotine dependence, sponsored by Pierre Fabre Laboratories. Started Feb 2015; status: completed.
02
Drugs
Nicopass
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02359201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359201.